Research and Markets (http://www.researchandmarkets.com/research/bpvjdz/cancer_cachexia) has announced the addition of the "Cancer Cachexia Global Clinical Trials Review, H2, 2013" report to their offering.

Cancer Cachexia Global Clinical Trials Review, H2, 2013" provides data on the Cancer Cachexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cancer Cachexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cancer Cachexia.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Top Companies Participating in Cancer Cachexia Therapeutics Clinical Trials

  • Helsinn Holding S.A.
  • XBiotech USA, Inc.
  • Ohr Pharmaceutical Inc.
  • Ark Therapeutics Group plc
  • GTx, Inc.
  • DiaLean, Ltd.
  • B. Braun Melsungen AG
  • Acacia Pharma Ltd.

Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center

  • National Cancer Institute
  • Cantonal Hospital
  • U.S. Department of Veterans Affairs
  • VU University Medical Center
  • Radiation Therapy Oncology Group
  • Case Comprehensive Cancer Center
  • University Hospital Freiburg
  • Medical University of Vienna
  • Universitaire Ziekenhuizen Leuven

For more information visit http://www.researchandmarkets.com/research/bpvjdz/cancer_cachexia

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals